N494 Module 5 Systematic Review Appraisal Example

Reviewed by Maren Hollowell, MSN, RN Aspen University Updated October 2026

This N494 Module 5 sample paper appraises Lee and Tamale's 2023 meta-analysis of inhaled isopropyl alcohol for emergency department nausea, which pooled two trials and 195 patients. In Aspen University's Essentials of Nursing Research, the middle modules move up the evidence hierarchy, and this RN to BSN paper judges a systematic review with the AMSTAR 2 tool from Shea and colleagues. It summarizes the review's question and pooled result, credits the critical domains it meets, including its handling of a third trial with a different comparison, and names its main limitation: a small evidence base. It explains why a moderate GRADE rating is not a weak endorsement and compares the review with Hines's Cochrane work on postoperative nausea. The conclusion separates sound methods from strong evidence.

CourseN494 Essentials of Nursing Research
ModuleModule 5
Paper typeSystematic review appraisal
LengthAbout 1,045 words, 6 pages
FormatAPA 7 student paper
SchoolAspen University
ProgramRN to BSN
UpdatedOctober 2026

Free sample paper for N494 Module 5

1

Two Trials, 195 Patients, One Pooled Answer: Appraising a Meta-Analysis of Inhaled Isopropyl Alcohol for Emergency Department Nausea

Student Name

RN to BSN Program, Aspen University

N494: Essentials of Nursing Research

Instructor Name

Month Day, Year

What this page is doingThe title puts the review's size in the foreground because size is the review's central limitation, which a strong appraisal will weigh. It also names the question the review answers so the grader sees the connection to the course's running PICOT. APA 7 student title page.
2

Two Trials, 195 Patients, One Pooled Answer: Appraising a Meta-Analysis of Inhaled Isopropyl Alcohol for Emergency Department Nausea

Systematic reviews and meta-analyses sit at the top of most evidence hierarchies because they combine the results of several studies using explicit, reproducible methods. Their position does not guarantee quality. A review built on few or weak studies, or conducted with shortcuts, can give a false sense of certainty. This paper appraises a systematic review and meta-analysis by Lee and Tamale (2023) of inhaled isopropyl alcohol for nausea in adult emergency department patients, the population in the clinical question developed in Module 1. The appraisal uses selected domains of AMSTAR 2, a widely used tool for judging the confidence one can place in a systematic review (Shea et al., 2017).

What this page is doingThe introduction explains why systematic reviews are prized and then immediately cautions that position is not quality, which sets up a critical rather than deferential appraisal. Naming AMSTAR 2 shows use of an established, citable tool.
3

The Review in Brief

The review asked whether inhaled isopropyl alcohol reduces nausea, compared with usual care or placebo, in emergency department adults whose chief complaint is nausea or vomiting. The authors registered a protocol in PROSPERO, searched MEDLINE, Embase, the Cochrane Central Register of Controlled Trials, trial registries, journals, and conference proceedings through September 2022, and included only randomized controlled trials. Its main endpoint was how much nausea severity changed on a validated scale; the secondary outcome was vomiting during the emergency department stay. Certainty of evidence was rated with the GRADE system (Lee & Tamale, 2023).

Two trials comparing inhaled isopropyl alcohol with saline placebo, with a total of 195 patients, were pooled for the primary analysis. The pooled mean reduction in nausea was 2.18 points on a 0 to 10 scale in favor of isopropyl alcohol (95% CI [1.60, 2.76]), above the minimum clinically important difference of 1.5 that the authors had defined. A third trial, which compared isopropyl alcohol plus ondansetron with saline plus ondansetron, did not meet the registered protocol and was included only in a secondary analysis. The authors graded the evidence as moderate because of imprecision from small numbers and concluded that isopropyl alcohol likely has a modest effect compared with placebo (Lee & Tamale, 2023).

What this page is doingThe summary reports the question, protocol registration, search, inclusion criteria, outcomes, pooled effect with its confidence interval and the certainty rating. Stating the minimum clinically important difference alongside the effect lets the grader see that the writer understands clinical, not just statistical, significance.
4

Strengths Against AMSTAR 2

Several critical AMSTAR 2 domains are met. The review was registered in advance, which protects against changing methods after seeing the data (Shea et al., 2017). The search was broad, covering multiple databases, trial registries, and conference proceedings, which reduces the chance of missing unpublished trials. Risk of bias was assessed for each included study, and all were judged at low or unclear risk. Certainty was rated with GRADE, and the authors downgraded it for imprecision rather than overstating it.

The handling of the third trial deserves credit. Because that trial compared two active combinations rather than isopropyl alcohol with placebo, it did not fit the registered question, and the authors kept it out of the primary analysis while reporting it separately. Honoring the protocol when a relevant study does not quite fit is exactly the discipline that registration is meant to enforce.

What this page is doingStrengths are tied to named AMSTAR 2 domains with an explanation of why each matters. The highlighted sentence recognizes a subtle strength, protocol fidelity, that many student appraisals would miss or misread as a weakness.
5

Limitations

The review's main limitation is the size of its evidence base. Two trials and 195 patients cannot establish how consistent the effect is across settings, and heterogeneity statistics mean little with so few studies. Both pooled trials compared isopropyl alcohol with saline placebo, so the review cannot answer the comparison most relevant to practice: whether isopropyl alcohol is as good as or better than a standard antiemetic. The trials were also short, measuring nausea over minutes rather than hours.

A second limitation comes from the included studies rather than the review. Isopropyl alcohol has a distinctive odor that saline lacks, so patients in the included trials could often tell which treatment they received, and nausea is a subjective outcome. The review's risk-of-bias ratings of low or unclear should be read with that in mind. Finally, the vomiting outcome was assessed in only one trial, which found no difference, so the review offers no evidence that isopropyl alcohol reduces vomiting (Lee & Tamale, 2023). A full AMSTAR 2 appraisal would also confirm, from the full text, whether study selection and data extraction were done in duplicate and whether the list of excluded studies was reported.

What this page is doingLimitations include both the review's own constraints and those it inherits from its trials, and the paper is specific about what the review cannot answer. The final sentence identifies the remaining AMSTAR 2 items to verify, which is honest about the scope of the appraisal.
6

Overall Confidence and Implications

Under AMSTAR 2, a review is rated by the number and severity of weaknesses in its critical domains rather than by a total score (Shea et al., 2017). Based on the domains assessed here, this review appears methodologically sound, and the main reason for caution is the thin evidence it had to work with rather than flaws in how it was done. Its conclusion that isopropyl alcohol likely has a modest benefit over placebo is appropriately hedged.

The GRADE rating deserves a closer look, because nurses often read "moderate" as a weak endorsement. In GRADE, moderate certainty means the true effect is probably close to the estimate but could be substantially different. Here the downgrade came from imprecision, not from bias or inconsistency, so readers can be fairly sure which way the effect points and the uncertainty lies mostly in its size. The lower end of the confidence interval, 1.60 points, still exceeds the minimum clinically important difference of 1.5, so even the most pessimistic estimate consistent with the data describes a benefit patients would notice.

For the clinical question, the review supports the idea that inhaled isopropyl alcohol provides quick, clinically meaningful short-term relief compared with doing nothing, which is essentially the situation of a patient waiting in a fast-track area. Combined with a Cochrane review showing faster relief and less need for rescue antiemetics than standard treatment in postoperative patients (Hines et al., 2018), and with the emergency department trial that compared it directly with ondansetron (April et al., 2018), the evidence is consistent in direction. It is not yet strong enough to replace antiemetics, but it is strong enough to consider isopropyl alcohol as a first step offered at triage while evaluation proceeds.

What this page is doingThe overall judgment follows AMSTAR 2's own logic (critical weaknesses, not a total score), separates review quality from evidence strength, and then situates the review within the rest of the evidence gathered in the course. The practice implication is carefully proportioned to the evidence.
7

Conclusion

Lee and Tamale's (2023) review is a well-conducted synthesis of a small body of evidence. It was registered, searched broadly, assessed bias, rated certainty honestly, and kept to its protocol. Its conclusions are limited by two trials, 195 patients, a placebo rather than active comparison, short follow-up, and imperfect blinding in the underlying studies. Appraised with AMSTAR 2, it earns reasonable confidence in its methods and appropriate caution about its answer.

What this page is doingThe conclusion summarizes strengths and limitations in parallel and ends on a precise statement of confidence. Separating confidence in methods from confidence in the answer is the central skill a systematic review appraisal is meant to demonstrate.
8

References

April, M. D., Oliver, J. J., Davis, W. T., Ong, D., Simon, E. M., Ng, P. C., & Hunter, C. J. (2018). Aromatherapy versus oral ondansetron for antiemetic therapy among adult emergency department patients: A randomized controlled trial. Annals of Emergency Medicine, 72(2), 184-193. https://doi.org/10.1016/j.annemergmed.2018.01.016

Hines, S., Steels, E., Chang, A., & Gibbons, K. (2018). Aromatherapy for treatment of postoperative nausea and vomiting. Cochrane Database of Systematic Reviews, (3), Article CD007598. https://doi.org/10.1002/14651858.CD007598.pub3

Lee, S. Y., & Tamale, J. R. (2023). Isopropyl alcohol inhalation for the treatment of nausea in adult emergency department patients: A systematic review and meta-analysis. Emergency Medicine Journal, 40(9), 660-665. https://doi.org/10.1136/emermed-2022-212871

Shea, B. J., Reeves, B. C., Wells, G., Thuku, M., Hamel, C., Moran, J., Moher, D., Tugwell, P., Welch, V., Kristjansson, E., & Henry, D. A. (2017). AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ, 358, Article j4008. https://doi.org/10.1136/bmj.j4008

What the N494 Module 5 instructions ask for

Aspen's N494 moves through appraisal of different kinds of evidence, and a middle module commonly asks for a critical appraisal of a systematic review or meta-analysis on your topic, using a recognized tool. Your classroom names the tool and the length. Summarize the review's question, search, included studies and main result. Apply the tool domain by domain, giving extra weight to the critical domains. Separate the quality of the review's methods from the strength of the evidence it pooled. Explain the GRADE or certainty rating in plain words. Compare the review with other reviews you found. Then state what it means for your practice question, being clear about which patients the pooled result covers and which it does not.

How this N494 Module 5 example is built

The introduction explains why reviews sit at the top of most hierarchies. The overview states Lee and Tamale's question and the pooled analysis of two placebo-controlled trials with 195 patients. The strengths section works through critical AMSTAR 2 domains, including protocol, search, risk of bias and the decision to analyze a third trial separately because its comparison differed. The limitations section names the small number of trials and limits that come from the included studies. The confidence section explains that AMSTAR 2 rates reviews by weaknesses in critical domains, not by a score, and looks closely at what a moderate GRADE rating means. It places the result beside Hines's Cochrane review. The conclusion calls the review well conducted but built on little evidence.

Reading the N494 Module 5 grading rubric

Systematic review appraisals are marked for accurate summary, correct use of the appraisal tool, distinction between method and evidence, implications and APA writing. On the tool row, the sample scores by applying AMSTAR 2 by domain and explaining its rating logic. The distinction between a well-done review and a small evidence base is drawn explicitly, which is the insight graders most want. GRADE is explained rather than repeated. Lee and Tamale's 2023 review, Shea's 2017 BMJ article introducing AMSTAR 2, Hines's 2018 Cochrane review and April's 2018 trial form the N494 reference list. Implications are stated with their limits, so the reader knows what the review supports and what remains uncertain.

N494 Module 5 help from the desk

The common mistake in this module is treating a meta-analysis as automatically strong. A careful review of two small trials is still a small evidence base. Another is applying the appraisal tool by listing yes and no answers without explaining them. Give a sentence of reasoning for each critical domain. Students also confuse the review's risk of bias assessment with their own appraisal of the review. Keep them separate. Do not misstate the GRADE rating; quote it and explain it. Check the number of trials and patients against the review's own results section. Sections that assign the JBI checklist instead can follow this same pattern with that tool. Finally, end on what a nurse can and cannot conclude.

Write yours, or have the desk draft it

This paper is an original model document written by our desk, not a submitted student paper and not an official Aspen University document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.

More N494 and RN to BSN sample papers

N494 Module 5 questions, answered

What does N494 Module 5 usually ask for?

N494 moves through appraisal of different kinds of evidence, and a middle module commonly focuses on higher-level evidence such as systematic reviews, along with how evidence-based practice is supported in organizations. Aspen does not publish module deliverables, so your classroom's instructions set the exact task.

What is AMSTAR 2?

A critical appraisal tool for systematic reviews of healthcare interventions. It covers items such as protocol registration, search comprehensiveness, duplicate selection and extraction, risk-of-bias assessment and appropriate meta-analysis, and it rates overall confidence based on weaknesses in critical domains rather than a total score.

Can a well-done systematic review still give a weak answer?

Yes. Methods and evidence are separate questions. The sample's review follows sound methods but pools only two trials and 195 patients, so its answer is modest and its certainty moderate. Good appraisals say both things clearly.

Where can I find a free N494 Module 5 sample paper?

You can read the whole N494 Module 5 appraisal above, applying AMSTAR 2 to a meta-analysis of inhaled isopropyl alcohol for emergency nausea.

How do I use AMSTAR 2 in the N494 systematic review appraisal?

Answer each domain, give extra attention to the critical ones, and rate overall confidence by the number and seriousness of critical weaknesses rather than by adding up points.